Screening for Lung Problems in People With Rheumatoid Arthritis
Studies how to find lung problems early in adults with rheumatoid arthritis.
Plain-language title generated from the registry record
Registry title: Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
Key facts
- Where
- Innsbruck, AustriaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with rheumatoid arthritis who live in Austria. It aims to build a screening plan for lung and pleura problems linked to the disease.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Rheumatoid arthritis diagnosed according to current ACR/EULAR criteria
Main reasons for not taking part
- Pregnancy
- Under 18 years of age
- Cannot have the routine study examinations, for example because of needle phobia (cannot have blood drawn) or claustrophobia (cannot have a CT scan)
Read by machine on 9 November 2026.
Where in Austria
- Medical University InnsbruckInnsbruck, AustriaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Medical University Innsbruck
- Trial code
- NCT06965322
- Record updated
- 2 December 2025
- Original description
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).Read full original descriptionShow less
Prospective Observational Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
Inclusion: Patients ≥18 years diagnosed with rheumatoid arthritis according to current ACR/EULAR criteria; Residence in Austria; Signed and dated consent of the patient in accordance with ICH-GCP guidelines.
Exclusion: age below 18 years; pregnancy; Contraindications to study-related routine examinations (e.g., inability to draw blood due to needle phobia, no CT scan possible due to claustrophobia, pregnancy, etc.).